Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Top 20 Shareholders 14 December 2018

Top_Holders_Report (14)Download

Category: News & Announcements 2018By Richard Mollard December 17, 2018

Related posts

Top 20 Shareholders 30th December 2018
January 7, 2019

PharmAust Manufacturing Method Maintains Drug Potency
December 2, 2018

GMP Tablet Production for Clinical Trials Commences
November 13, 2018

2018 AGM Results
November 9, 2018

2018 AGM Presentation
November 9, 2018

Top 20 Shareholders 31st October 2018
November 6, 2018

Recent Articles

14 September, Shareholder Update
September 14, 2020
Elanco not to Exercise Agreed Option
September 9, 2020
Monepantel Anti-Covid-19 Activity Confirmed
September 9, 2020
August 31, Top 20 Shareholders
September 1, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Epichem @epichem·

We can assure you the highest quality product for our #ReferenceMaterials production & testing, which are accredited to the highest achievable recognised international standards #ISO17034 & #ISO17025. And we’re proud of our quality management system: certified to #ISO9001.

Reply on Twitter 1305715473431097345 Retweet on Twitter 13057154734310973452 Like on Twitter 13057154734310973454 Twitter 1305715473431097345

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions